Nasdaq
$1.57▲ 0.32%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $105.2MShares out 67.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
9- 9.24After-hours26.09.25 05:404Ownership#●●●
enGene Therapeutics Inc.
Executive William Grossman of enGene Therapeutics Inc. reported a change in his beneficial ownership of securities effective September 22, 2026. This filing serves as a standard Form 4 disclosure regarding insider stock holdings.…more
$1.57+0.32%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.8Pre-market26.09.08 20:3610-QEarnings
enGene Therapeutics Inc.
enGene has reorganized its leadership team by appointing a new Senior Vice President of Finance and entering into separation agreements with two existing executives. The departing executives will receive severance payments of $517,880 and $473,796, respectively, as part of the company's organizational restructuring.…more
$1.57+0.32%vs prev closeView filingShare - 9.8Pre-market26.09.08 20:338-KKey event
enGene Therapeutics Inc.
enGene Therapeutics reported its financial results for the third quarter ended July 31, 2026, with $266.3 million in cash, cash equivalents, and marketable securities. The company plans to initiate a Biologics License Application (BLA) submission for detalimogene in the fourth quarter of 2026, alongside a scheduled pre-BLA meeting with the FDA. The net loss for the third quarter of 2026 was approximately $32.5 million, or $0.47 per share.…more
$1.57+0.32%vs prev closeView filingShare
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.8Pre-market26.09.08 20:42Bullish#●●●
enGene Holdings Q3 EPS Misses Estimates
enGene Holdings reported a quarterly loss of $0.47 per share, missing the analyst consensus estimate of $0.43. While the loss narrowed compared to the same period last year, the earnings miss may weigh on investor sentiment.…more
$1.57+0.32%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga